Publication

TRIM8 regulates stemness in glioblastoma through PIAS3-STAT3

Downloadable Content

Persistent URL
Last modified
  • 03/03/2025
Type of Material
Authors
    Changming Zhang, Emory UniversitySubhas Mukherjee, Emory UniversityCarol Tucker-Burden, Emory UniversityJames L. Ross, Emory UniversityMonica J. Chau, Emory UniversityJun Kong, Emory UniversityDaniel Brat, Emory University
Language
  • English
Date
  • 2017-03-01
Publisher
  • Wiley
Publication Version
Copyright Statement
  • © 2017 The Authors.
License
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 1574-7891
Volume
  • 11
Issue
  • 3
Start Page
  • 280
End Page
  • 294
Grant/Funding Information
  • This work was supported by US Public Health Service National Institutes of Health (NIH) Grants R01 CA176659 (DJB), CA149107 (DJB), and K25CA181503 (JK); the Winship Cancer Institute NCI Cancer Center Support Grant P30CA138292; and the Georgia Research Alliance (DJB).
Supplemental Material (URL)
Abstract
  • Glioblastoma (GBM) is the most malignant form of primary brain tumor, and GBM stem-like cells (GSCs) contribute to the rapid growth, therapeutic resistance, and clinical recurrence of these fatal tumors. STAT3 signaling supports the maintenance and proliferation of GSCs, yet regulatory mechanisms are not completely understood. Here, we report that tri-partite motif-containing protein 8 (TRIM8) activates STAT3 signaling to maintain stemness and self-renewing capabilities of GSCs. TRIM8 (also known as 'glioblastoma-expressed ring finger protein') is expressed equally in GBM and normal brain tissues, despite its hemizygous deletion in the large majority of GBMs, and its expression is highly correlated with stem cell markers. Experimental knockdown of TRIM8 reduced GSC self-renewal and expression of SOX2, NESTIN, and p-STAT3, and promoted glial differentiation. Overexpression of TRIM8 led to higher expression of p-STAT3, c-MYC, SOX2, NESTIN, and CD133, and enhanced GSC self-renewal. We found that TRIM8 activates STAT3 by suppressing the expression of PIAS3, an inhibitor of STAT3, most likely through E3-mediated ubiquitination and proteasomal degradation. Interestingly, we also found that STAT3 activation upregulates TRIM8, providing a mechanism for normalized TRIM8 expression in the setting of hemizygous gene deletion. These data demonstrate that bidirectional TRIM8-STAT3 signaling regulates stemness in GSC.
Author Notes
  • Correspondence: D. J. Brat, Department of Pathology and Laboratory Medicine, Emory University Hospital, H‐195 1364 Clifton Rd. NE. Atlanta, GA 30322, USA Tel: 404 712 1266 E‐mail: dbrat@emory.edu
Keywords
Research Categories
  • Health Sciences, General
  • Health Sciences, Oncology

Tools

Relations

In Collection:

Items